Valproate Teratogenicity A Moving Target

Gruppuso, PA; Ahmed, R; Adashi, EY

Gruppuso, PA (通讯作者),Rhode Isl Hosp, Div Pediat Endocrinol, Providence, RI 02903 USA.

OBSTETRICS AND GYNECOLOGY, 2022; 140 (3): 408

Abstract

Within several years after receiving U.S. Food and Drug Administration (FDA) approval in the late 1970s, valproate was shown to increase the risk for ......

Full Text Link